Global Biologics Market Overview And Top Key Players by 2030Posted by srikanth on February 8th, 2021 The Biologics Global Market Report 2020-30 by The Business Research Company describes and explains the global biologics market and covers 2015 to 2020, termed the historic period, and 2020 to 2025, termed the forecast period, along with further forecasts for the period 2025-2030. The report evaluates the market across each region and for the major economies within each region. The Biologics Global Market Report 2021 covers biologics market drivers, biologics market trends, biologics market segments, biologics market growth rate, biologics market major players, and biologics market size. View Complete Report: https://www.thebusinessresearchcompany.com/report/biologics-global-market-report The biologics market report provides an in-depth analysis of the impact of COVID-19 on the global biologics industry, along with revised market numbers due to the effects of the coronavirus and the expected biologics market growth numbers 2021-2030. Biologics Global Market Report 2021 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market. The chapter also covers markets which have been positively affected by the pandemic.
The global biologics market is expected to grow from 3.41 billion in 2020 to 8.51 billion in 2021 at a compound annual growth rate (CAGR) of 6%. The market is expected to reach 0.55 billion in 2025 at a CAGR of 12%. The report covers the biologics market’s segments- 2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others. 3) By Route Of Administration: Oral, Parenteral, Others. 4) By Drug Classification: Branded Drugs, Generic Drugs. 5) By Mode Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs. Subsegments Covered: Anti-Cancer MAbs, Immunological MAbs, Anti-Infective Monoclonal Antibodies (MAbs), Neuropharmacological MAbs, Cardiovascular And Cerebrovascular MAbs, Other Monoclonal Antibodies (MAbs), Metabolic Disorders Therapeutic Proteins, Cancer Therapeutic Proteins, Cardiovascular Therapeutic Proteins, Immunological Therapeutic Proteins, Other Therapeutic Proteins, Anti-Infective Vaccines, Autoimmunity Vaccines, Other Vaccines. About The Business Research Company: Contact Information: Asia: +91 8897263534 Americas: +1 315 623 0293 Email: info@tbrc.info Like it? Share it! More by this author |